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Introduction
The topic of Pulmonary Embolism (PE)
was selected because the author, Jill
Parker BSN, RN, works in the Riverside
Hospital Emergency Department (ED). In
the ED, diagnoses of Pulmonary
Embolism are common, and are often not
obvious when a patient arrives with chest
pain or shortness of breath. However,
quick recognition and treatment of PEs
are very important.
By creating this poster, the author
hopes to provide a summary of current
research that explains signs and
symptoms of a Pulmonary Embolism, the
underlying pathophysiology of the
condition, and an explanation about why
that is significant. This important
information, together with information
about treatment and prevention, can
serve as an accessible way to help
educate patients about the condition.
As an Advanced Practice Nurse, the
author plans to continue working with
emergent patients, where fast and
accurate diagnostic and treatment skills
are crucial. Patient education is an
important resource in recognizing
symptoms of PEs and knowing that they
require immediate treatment.

Prevalence of PE
Pulmonary embolism, together with
deep venous thrombosis (DVT), are often
together referred to as venous
thromboembolism. In the United States,
the CDC estimates that:
• Approximately 900,000 people
develop VTE each year

Signs and Symptoms
Patients with a pulmonary embolism
often present with a set of nonspecific
symptoms. Therefore, it is important for
the general population to understand
symptoms that might indicate PE. These
include leg pain, swelling, or both, often
in the calf, shortness of breath, chest
pain, fever, excessive sweating,
discolored or clammy skin,
lightheadedness, and a rapid or irregular
heartbeat ("Pulmonary embolism:
Overview - Mayo Clinic," 2016).
However, the actual diagnosis of PE
requires careful clinical judgment. At
one end of the spectrum, patients may
be completely asymptomatic, while at
the other end they may present with
cardiogenic shock. Other symptoms that
indicate more severe PE include
hypotension, hypoxia, tachycardia,
elevation of B-type natriuretic peptides
or N-terminal pro-B-type natriuretic
peptides or troponins, and EKG changes
that suggest right ventricular strain
(Shapiro & Bhatt, 2016, p. 36).
There are both acquired and genetic
risk factors for PE. Acquired factors
include immobilization, the use of oral
contraceptives or hormone replacement
therapy, older age, a malignancy, trauma
or fractures, pregnancy or having
recently given birth, as well as obesity,
and certain types of cardiac or
neurologic disease, and a prior history
or family history of DVT. The use of
central venous catheters or peripheral
central catheter lines, immobilization,
and postoperative infections are also
conditions that carry a high risk of PE.

Pathophysiological Processes
Genetic risk factors include protein C or
S deficiency, antothrombin deficiency,
factor V Leiden and prothrombin 20210A
gene variants, non-O blood groups
(Coleman, Obi & Henke, 2015, p. 2-3).

Underlying
Pathophysiology

A pulmonary embolism that travels to
the heart causes cardiac failure due to
increased wall stress and cardiac
ischemia that makes up the Right
Ventricle function and impairs the Left
Ventricular output. The embolism itself
initiates the cycle shown below and to the
left.

Path of a PE
The embolism travels to the heart and
causes pressure on the right ventricle as
well as an inadequate blood supply. That
leads to increased right ventricle volume,
which results in a decreased left ventricle
preload, which in turn causes decreased
Cardiac Output (CO) and Mean Arterial
Pressure (MAP). This leads to decrease
right ventricle Coronary Perfusion
Pressure(CPP), which starts the cycle over
again. Wood, 2002, p. 881-882).

The basic underlying cause of PEs is a
blockage in one of the pulmonary
arteries. Usually, blood clots originate in
the legs, break off, and travel to the
lungs where they block blood flow. A
high level view of this process is
illustrated in Figure 2 ("Pulmonary
embolism: Overview - Mayo Clinic,"
2016).
Current
scientific thinking suggests that the
embolism event occurs at the wall of the
vein. This includes the inflammatory
responses to, as well as the cause of the
clot formation. After a vascular injury,
platelets form a hemostatic plug and
start the aggregation process. A platelet
plug is formed, and then coagulation
protein assembles and form a clot
(Coleman, Obi & Henke, 2015, p. 4).
If the blood clot breaks off and passes to
the heart, it can cause cardiac failure.
The underlying pathophysiological
process of that cardiac failure is
described in Figure 1 (Wood, 2002,
p. 882).

Significance of
Pathophysiology

Figure 1. Pathophysiology of Cardiac Failure Caused by Pulmonary Embolism

• Ten to thirty percent of patients die
within a month of diagnosis

Therefore, it is extremely important to
recognize the risk factors and symptoms
of pulmonary embolism so that it can be
avoided or treated immediately.

The diagnosis has implications to
nursing care, as nurses must be able to
educate patients about the causes and
effects of the condition, the importance
of treatment and follow up care, and
emphasize steps to take to avoid another
PE. Nurses should assess and discuss
each patient’s risk factors and ways to
specifically lower chances of a
recurrence of the condition. In addition,
they should ensure they patient
recognizes any warning signs and new
symptoms, and has a plan of action if
symptoms do recur.

Figure 3 – Detailed View of Pulmonary
Embolism

• Of that number, 60,000 to 100,000 die

• Sudden death is the first symptom in
approximately 25% of that population

Figure 3 below provides a more
detailed view of a PE. A blood clot forms
in the lung, travels through the
bloodstream to the heart and through it,
and then obstructs a blood vessel in the
lung.
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Figure 2 – Illustration of Pulmonary Embolism

Because of the very high incidence of
morbidity and mortality in patients with
a pulmonary embolism, as well as the
difficulty in diagnosis, it is important
that at-risk patients be screened for PE.
The pathophysiology that leads to PE is
significant, because of the consequences
and risk associated with the diagnosis.
PE Patients who have been treated have
approximately an 8% mortality rate, and
in untreated patients the mortality rate
can be as high as 30% (Deng,
Li, Zhou, Liu, et al., 2015, p. 1).
Therefore, detection and prevention of
PE is critical.

Conclusion
The diagnosis of pulmonary
embolisms can be difficult, but the
condition is common and can have very
serious consequences. Doctors and
Advanced Practice Nurses must be aware
of the underlying pathophysiology of the
condition so they can effectively diagnose
and treat it. In addition, this knowledge
helps to educate patients about risk
factors, symptoms of the condition, the
importance of treatment, and ways to
prevent a recurrence..
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